Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC reaffirms FY 2017 revenue guidance-Conference Call


Thursday, 6 Feb 2014 02:00am EST 

AstraZeneca PLC:Expects FY 2017 revenues will be broadly in line with FY 2013.FY 2017 revenues of $23.46 bln - Thomson Reuters I/B/E/S. 

Company Quote

4683.0
-43.5 -0.92%
5:35am EDT